Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37

Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by <i>Staphylococcus aureus</i>

Vance G. Fowler, Helen W. Boucher, G. Ralph Corey et al. · New England Journal of Medicine · 2006 · 1.5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Use of Vancomycin or First-Generation Cephalosporins for the Treatment of Hemodialysis-Dependent Patients with Methicillin-Susceptible Staphylococcus aureus Bacteremia

Martín E. Stryjewski, Lynda A. Szczech, Danny Benjamin et al. · Clinical Infectious Diseases · 2006 · 346 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

Outcome of Vancomycin Treatment in Patients with Methicillin-Susceptible<i>Staphylococcus aureus</i>Bacteremia

Sung‐Han Kim, Hong Bin Kim, Nam Joong Kim et al. · Antimicrobial Agents and Chemotherapy · 2007 · 297 citations

Life Sciences, Infectious Diseases, Microbiology +13

Use of Antistaphylococcal  -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding

Abhay Dhand, Arnold S. Bayer, Joe Pogliano et al. · Clinical Infectious Diseases · 2011 · 254 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

Marin L. Schweizer, Jon P. Furuno, Anthony D. Harris et al. · BMC Infectious Diseases · 2011 · 252 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15